Premature ventricular contraction-induced dilated cardiomyopathy: a case report. Issue 1 (25th February 2019)

• Record Type: Journal Article
• Authors: Sen, Jonathan; Amerena, John
• Editors: Tor-Biering-Sørensen, ; Akleh, Subh; Hasan, Hosam; Akhtar, Mohammed; Green, Peregrine
• Is Part Of: European heart journal. Volume 3:Issue 1(2019)
• Publication Date: 2019-02-25
• Subjects: Cardiomyopathy -- Case report -- Catheter ablation -- Dilated cardiomyopathy -- Heart failure -- Premature ventricular complexes; Cardiology -- Periodicals; Cardiology -- Case studies -- Periodicals; Heart -- Diseases -- Periodicals; Heart -- Diseases -- Case studies -- Periodicals; 616.12
• DOI: 10.1093/ehjcr/ytz016
• Languages: English
• ISSNs: 2514-2119

Abstract

Abstract: Background: Premature ventricular complexes (PVCs) are ectopic heartbeats caused by early myocardial depolarizations, previously thought to be benign. Recent studies found high PVC burden above 24% can induce or contribute to cardiomyopathy and heart failure. We present a case of PVC-induced dilated cardiomyopathy (DCM). Case summary: A 68-year-old woman was admitted with pneumonia after an overseas trip with a preceding viral respiratory tract infection. An initial chest X-ray was suggestive of cardiomegaly. A transthoracic echocardiogram (TTE) revealed DCM with global systolic dysfunction (left ventricular ejection fraction <30%) without valvular lesions. Biochemistry and coronary angiography were normal. Clinical deterioration occurred despite medical therapy. A 24-h Holter monitoring detected 27% PVCs, which was thought to have caused DCM. As an alternative to cardiac resynchronization therapy and an implantable cardiac defibrillator for primary prevention, ablation of the PVC focus led to complete suppression of ectopy. Post-procedure TTEs and Holter monitoring showed normalized systolic function and low PVC burden. Discussion: Because high PVC burden can lead to cardiomyopathy and heart failure, suppression of PVC should be considered to restore ventricular function for patients with structural heart disease and frequent symptomatic PVCs. This case highlights that PVCs may be a modifiable risk factor for heart failure that can be successfully treated with pharmacological therapies or catheter ablation.